Insights

Strategic AI proteins Aether Biomachines combines proprietary AI-driven protein discovery with high-throughput screening to develop real-world applications, presenting opportunities to partner on custom protein solutions for industrial processes, materials production, and environmental remediation.

Manufacturing efficiency Recent product initiatives include high-performance polymers and RapidPrint filament capable of faster, stronger 3D printing, signaling sales potential with defense, aerospace, and manufacturing sectors seeking cost reduction and performance gains.

Sustainability focus Temperature of markets and press statements indicate capabilities in breaking down persistent pollutants and capturing CO2, offering environmental tech collaborations or licensing deals with plastics/recycling, chemical, and energy industries aiming to improve sustainability metrics.

Strategic leadership Appointment of a new president and notable funding rounds suggest organizational scale-up and potential for enterprise partnerships, channel co-sell with equipment manufacturers, contract research, and joint ventures to accelerate deployment.

Industry engagement Active participation in industry events such as Formnext and demonstrated in-practice capabilities provide networking avenues for customer discovery, pilot collaborations, and early-adopter programs in additive manufacturing, materials science, and biotechnology markets.

Aether Tech Stack

Aether uses 8 technology products and services including AS9100, Cloudflare, Google Workspace, and more. Explore Aether's tech stack below.

  • AS9100
    Certificates
  • Cloudflare
    Content Management System
  • Google Workspace
    Email
  • Lenis
    Javascript Libraries
  • HubSpot
    Marketing Automation
  • Microsoft
    Miscellaneous
  • Webflow
    Page Builders
  • Graphene
    Web Platform Extensions

Media & News

Aether's Email Address Formats

Aether uses at least 1 format(s):
Aether Email FormatsExamplePercentage
First@aetherbio.comJohn@aetherbio.com
86%
FLast@aetherbio.comJDoe@aetherbio.com
14%

Frequently Asked Questions

What is Aether's stock symbol?

Minus sign iconPlus sign icon
Aether is a publicly traded company; the company's stock symbol is GMFI.

What is Aether's official website and social media links?

Minus sign iconPlus sign icon
Aether's official website is aetherbio.com and has social profiles on LinkedInCrunchbase.

What is Aether's SIC code NAICS code?

Minus sign iconPlus sign icon
Aether's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Aether have currently?

Minus sign iconPlus sign icon
As of July 2026, Aether has approximately 89 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Head Of Catalytic Reactor Engineering: A. R.Head Of Business Development, Materials: G. C.Founder: Z. S. W.. Explore Aether's employee directory with LeadIQ.

What industry does Aether belong to?

Minus sign iconPlus sign icon
Aether operates in the Biotechnology Research industry.

What technology does Aether use?

Minus sign iconPlus sign icon
Aether's tech stack includes AS9100CloudflareGoogle WorkspaceLenisHubSpotMicrosoftWebflowGraphene.

What is Aether's email format?

Minus sign iconPlus sign icon
Aether's email format typically follows the pattern of First@aetherbio.com. Find more Aether email formats with LeadIQ.

How much funding has Aether raised to date?

Minus sign iconPlus sign icon
As of July 2026, Aether has raised $64M in funding. The last funding round occurred on Dec 03, 2025 for $320K.

When was Aether founded?

Minus sign iconPlus sign icon
Aether was founded in 2017.
Aether logo

Aether

Biotechnology ResearchCalifornia, United States51-200 Employees

Aether Biomachines, Inc. operates at the intersection of biotechnology research and artificial intelligence, focusing on discovering proteins with practical, real-world applications. Its work centers on a Protein Function Model supported by an in-house proprietary dataset developed through high-throughput screening and innovative assay techniques. The company reports seven new protein classes that enable functions including refining metals at lower cost, breaking down persistent pollutants, producing advanced materials, supporting pharmaceutical manufacturing, recycling plastics, and capturing carbon dioxide, with materials claimed to print ten times faster than current benchmarks and to offer enhanced strength for defense and aerospace.

Headquartered in Menlo Park, California, the firm positions itself in the biotechnology research sector by leveraging AI-designed proteins to address industrial-scale challenges. In late 2025, it introduced RapidPrint, a polymer filament product for high-performance 3D printing, reflecting a concrete product development.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
GMFI
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $64M

    Aether has raised a total of $64M of funding over 12 rounds. Their latest funding round was raised on Dec 03, 2025 in the amount of $320Kas a series_unknown.

  • $10M$25M

    Aether's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $64M

    Aether has raised a total of $64M of funding over 12 rounds. Their latest funding round was raised on Dec 03, 2025 in the amount of $320Kas a series_unknown.

  • $10M$25M

    Aether's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.